Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
Reduction of the risk of asthma attacks is a major goal of current asthma management. We propose to derive a risk scale predicting asthma attacks based on the blood eosinophil count and exhaled nitric oxide (FeNO). Biomarker-stratified trial-level attack rates were extracted and pooled from the cont...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021
|
| _version_ | 1797092233773580288 |
|---|---|
| author | Couillard, S Laugerud, A Jabeen, M Ramakrishnan, S Melhorn, J Hinks, T Pavord, I |
| author_facet | Couillard, S Laugerud, A Jabeen, M Ramakrishnan, S Melhorn, J Hinks, T Pavord, I |
| author_sort | Couillard, S |
| collection | OXFORD |
| description | Reduction of the risk of asthma attacks is a major goal of current asthma management. We propose to derive a risk scale predicting asthma attacks based on the blood eosinophil count and exhaled nitric oxide (FeNO). Biomarker-stratified trial-level attack rates were extracted and pooled from the control arms of the Novel START, CAPTAIN, QUEST, Benralizumab phase 2b, PATHWAY, STRATOS 1-2, and DREAM trials (n=3051). These were used to derive rate ratios and the predicted asthma attack rate for different patient groups. The resultant prototype risk scale shows potential to predict asthma attacks which may be prevented by anti-inflammatory treatment. |
| first_indexed | 2024-03-07T03:43:16Z |
| format | Journal article |
| id | oxford-uuid:be9a7aed-5691-4961-b8f5-1ad8cc0523b0 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:43:16Z |
| publishDate | 2021 |
| publisher | BMJ Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:be9a7aed-5691-4961-b8f5-1ad8cc0523b02022-03-27T05:40:52ZDerivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxideJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:be9a7aed-5691-4961-b8f5-1ad8cc0523b0EnglishSymplectic ElementsBMJ Publishing Group2021Couillard, SLaugerud, AJabeen, MRamakrishnan, SMelhorn, JHinks, TPavord, IReduction of the risk of asthma attacks is a major goal of current asthma management. We propose to derive a risk scale predicting asthma attacks based on the blood eosinophil count and exhaled nitric oxide (FeNO). Biomarker-stratified trial-level attack rates were extracted and pooled from the control arms of the Novel START, CAPTAIN, QUEST, Benralizumab phase 2b, PATHWAY, STRATOS 1-2, and DREAM trials (n=3051). These were used to derive rate ratios and the predicted asthma attack rate for different patient groups. The resultant prototype risk scale shows potential to predict asthma attacks which may be prevented by anti-inflammatory treatment. |
| spellingShingle | Couillard, S Laugerud, A Jabeen, M Ramakrishnan, S Melhorn, J Hinks, T Pavord, I Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title | Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title_full | Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title_fullStr | Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title_full_unstemmed | Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title_short | Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| title_sort | derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide |
| work_keys_str_mv | AT couillards derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT laugeruda derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT jabeenm derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT ramakrishnans derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT melhornj derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT hinkst derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide AT pavordi derivationofaprototypeasthmaattackriskscalecentredonbloodeosinophilsandexhalednitricoxide |